Global Doramectin Market Growth 2025-2031

Publication ID:

LPI01251101

Publication Date:

January 27, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Doramectin market size is predicted to grow from US$ 139 million in 2025 to US$ 204 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.
Doramectin, white or white crystalline powder, no odor, moisture. Doramectin injection is a kind of medicine for pets. It is a new type of macrolide anti-parasite drug, which has a high effect on nematodes, insects and mites. The main function is to treat domestic animal nematode disease, blood lice, acaricosis and other ectoparasites.
United States market for Doramectin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Doramectin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Doramectin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Doramectin players cover Livzon Group Fuzhou Fuxing Pharmaceutical(China), Zoetis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淒oramectin Industry Forecast鈥� looks at past sales and reviews total world Doramectin sales in 2024, providing a comprehensive analysis by region and market sector of projected Doramectin sales for 2025 through 2031. With Doramectin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Doramectin industry.
This Insight Report provides a comprehensive analysis of the global Doramectin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Doramectin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Doramectin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Doramectin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Doramectin.
This report presents a comprehensive overview, market shares, and growth opportunities of Doramectin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Emulsifiable Concentrate(EC)
Water Soluble Granules(SG)
Water Dispersible Granules(WG)
Liquid(LI)
Others
Segmentation by Application:
Pesticides
Chemical Additives
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Livzon Group Fuzhou Fuxing Pharmaceutical(China)
Zoetis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Doramectin market?
What factors are driving Doramectin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Doramectin market opportunities vary by end market size?
How does Doramectin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Doramectin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Doramectin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Doramectin by Country/Region, 2020, 2024 & 2031
2.2 Doramectin Segment by Type
2.2.1 Emulsifiable Concentrate(EC)
2.2.2 Water Soluble Granules(SG)
2.2.3 Water Dispersible Granules(WG)
2.2.4 Liquid(LI)
2.2.5 Others
2.3 Doramectin Sales by Type
2.3.1 Global Doramectin Sales Market Share by Type (2020-2025)
2.3.2 Global Doramectin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Doramectin Sale Price by Type (2020-2025)
2.4 Doramectin Segment by Application
2.4.1 Pesticides
2.4.2 Chemical Additives
2.4.3 Others
2.5 Doramectin Sales by Application
2.5.1 Global Doramectin Sale Market Share by Application (2020-2025)
2.5.2 Global Doramectin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Doramectin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Doramectin Breakdown Data by Company
3.1.1 Global Doramectin Annual Sales by Company (2020-2025)
3.1.2 Global Doramectin Sales Market Share by Company (2020-2025)
3.2 Global Doramectin Annual Revenue by Company (2020-2025)
3.2.1 Global Doramectin Revenue by Company (2020-2025)
3.2.2 Global Doramectin Revenue Market Share by Company (2020-2025)
3.3 Global Doramectin Sale Price by Company
3.4 Key Manufacturers Doramectin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Doramectin Product Location Distribution
3.4.2 Players Doramectin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Doramectin by Geographic Region
4.1 World Historic Doramectin Market Size by Geographic Region (2020-2025)
4.1.1 Global Doramectin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Doramectin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Doramectin Market Size by Country/Region (2020-2025)
4.2.1 Global Doramectin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Doramectin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Doramectin Sales Growth
4.4 APAC Doramectin Sales Growth
4.5 Europe Doramectin Sales Growth
4.6 Middle East & Africa Doramectin Sales Growth
5 Americas
5.1 Americas Doramectin Sales by Country
5.1.1 Americas Doramectin Sales by Country (2020-2025)
5.1.2 Americas Doramectin Revenue by Country (2020-2025)
5.2 Americas Doramectin Sales by Type (2020-2025)
5.3 Americas Doramectin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Doramectin Sales by Region
6.1.1 APAC Doramectin Sales by Region (2020-2025)
6.1.2 APAC Doramectin Revenue by Region (2020-2025)
6.2 APAC Doramectin Sales by Type (2020-2025)
6.3 APAC Doramectin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Doramectin by Country
7.1.1 Europe Doramectin Sales by Country (2020-2025)
7.1.2 Europe Doramectin Revenue by Country (2020-2025)
7.2 Europe Doramectin Sales by Type (2020-2025)
7.3 Europe Doramectin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Doramectin by Country
8.1.1 Middle East & Africa Doramectin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Doramectin Revenue by Country (2020-2025)
8.2 Middle East & Africa Doramectin Sales by Type (2020-2025)
8.3 Middle East & Africa Doramectin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Doramectin
10.3 Manufacturing Process Analysis of Doramectin
10.4 Industry Chain Structure of Doramectin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Doramectin Distributors
11.3 Doramectin Customer
12 World Forecast Review for Doramectin by Geographic Region
12.1 Global Doramectin Market Size Forecast by Region
12.1.1 Global Doramectin Forecast by Region (2026-2031)
12.1.2 Global Doramectin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Doramectin Forecast by Type (2026-2031)
12.7 Global Doramectin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Livzon Group Fuzhou Fuxing Pharmaceutical(China)
13.1.1 Livzon Group Fuzhou Fuxing Pharmaceutical(China) Company Information
13.1.2 Livzon Group Fuzhou Fuxing Pharmaceutical(China) Doramectin Product Portfolios and Specifications
13.1.3 Livzon Group Fuzhou Fuxing Pharmaceutical(China) Doramectin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Livzon Group Fuzhou Fuxing Pharmaceutical(China) Main Business Overview
13.1.5 Livzon Group Fuzhou Fuxing Pharmaceutical(China) Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Doramectin Product Portfolios and Specifications
13.2.3 Zoetis Doramectin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂